Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaxchora in preventing cholera
NCT01895855Phase 3Completed
- Sponsor
- Bavarian Nordic
- Start
- Sep 2013
- Primary completion
- Nov 2014
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of cholera vaccine, live, oral in cholera, sponsored by Bavarian Nordic. Started Sep 2013; status: completed.
02
Drugs
cholera vaccine, live, oral
03
Conditions
cholera
Beyond the preview
Go deeper on NCT01895855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895855.